Cody Wenthur News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bipartisan bill backs pilot program to study the effects of psilocybin on combat PTSD.

By Jonah Beleckis | Wisconsin Public Radio As more Wisconsin clinics offer ketamine to treat depression, a local professor studying psychiatric treatments

Could psychoactive substances like psilocybin, MDMA and ketamine finally crack the code on treatment-resistant depression, anxiety or PTSD?

DAVID WAHLBERG A nonprofit started by the head of Promega Corp. to study psychedelic drugs for depression and other mental health conditions is getting its own headquarters in Fitchburg amid an expanding national profile for psychoactive medicine. Psychologists discuss how to address depression and anxiety in the age of COVID-19. The Usona Institute, formed by Promega CEO Bill Linton in 2014, is expected to move into a 93,000-square-foot facility on 17 acres adjacent to Promega’s Fitchburg campus in 2024. “The practices and the therapy that we’re embodying here have...

Health ‘There is a need for something new’: Applications open for UW-Madison’s psychoactive drug treatment master’s program May 19, 2021 8:01 PM Madalyn O'Neill Updated: MADISON, Wis. – Whether you’ve been infected or not, the coronavirus can leave its mark. Reports of depression and anxiety went up six fold during the pandemic, according to Boston College researchers. “The pandemic has really caused the burden of negative mental health outcomes to skyrocket,” said Cody Wenthur, an assistant professor of pharmacy at the University of Wisconsin – Mad...